Literature DB >> 20824796

Trends in hospitalizations for Pneumocystis jiroveci pneumonia among patients with rheumatoid arthritis in the US: 1996-2007.

Grant H Louie1, Zhong Wang, Michael M Ward.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20824796      PMCID： PMC3364004          DOI： 10.1002/art.27735

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  6 in total

1.  Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification.

Authors:  Elizabeth K Rasch; Rosemarie Hirsch; Ryne Paulose-Ram; Marc C Hochberg
Journal:  Arthritis Rheum       Date:  2003-04

2.  Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality.

Authors:  M M Ward; F Donald
Journal:  Arthritis Rheum       Date:  1999-04

3.  Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.

Authors:  B Godeau; V Coutant-Perronne; D Le Thi Huong; L Guillevin; G Magadur; M De Bandt; S Dellion; J Rossert; G Rostoker; J C Piette
Journal:  J Rheumatol       Date:  1994-02       Impact factor: 4.666

4.  Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001.

Authors:  Michael M Ward
Journal:  Arthritis Rheum       Date:  2004-04

5.  Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis.

Authors:  T Takeuchi; Y Tatsuki; Y Nogami; N Ishiguro; Y Tanaka; H Yamanaka; N Kamatani; M Harigai; J Ryu; K Inoue; H Kondo; S Inokuma; T Ochi; T Koike
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

6.  Postmarketing surveillance of the safety and effectiveness of etanercept in Japan.

Authors:  Takao Koike; Masayoshi Harigai; Shigeko Inokuma; Kazuhiko Inoue; Naoki Ishiguro; Junnosuke Ryu; Tsutomu Takeuchi; Yoshiya Tanaka; Hisashi Yamanaka; Koichi Fujii; Bruce Freundlich; Michio Suzukawa
Journal:  J Rheumatol       Date:  2009-03-30       Impact factor: 4.666
  6 in total
  6 in total

Review 1.  Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis.

Authors:  James A Grubbs; John W Baddley
Journal:  Curr Rheumatol Rep       Date:  2014-10       Impact factor: 4.592

Review 2.  Pathological and protective immunity to Pneumocystis infection.

Authors:  Taylor Eddens; Jay K Kolls
Journal:  Semin Immunopathol       Date:  2014-11-25       Impact factor: 9.623

Review 3.  Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-06

4.  Incidence and Risk Factors for Infections Requiring Hospitalization, Including Pneumocystis Pneumonia, in Japanese Patients with Rheumatoid Arthritis.

Authors:  Atsushi Hashimoto; Shiori Suto; Kouichiro Horie; Hidefumi Fukuda; Shinichi Nogi; Kanako Iwata; Hirotaka Tsuno; Hideki Ogihara; Misato Kawakami; Akiko Komiya; Hiroshi Furukawa; Toshihiro Matsui; Shigeto Tohma
Journal:  Int J Rheumatol       Date:  2017-10-18

5.  Transcriptomic and Proteomic Approaches to Finding Novel Diagnostic and Immunogenic Candidates in Pneumocystis.

Authors:  Taylor Eddens; Waleed Elsegeiny; David Ricks; Meagan Goodwin; William T Horne; Mingquan Zheng; Jay K Kolls
Journal:  mSphere       Date:  2019-09-04       Impact factor: 4.389

6.  National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia.

Authors:  Sara G Murray; Gabriela Schmajuk; Laura Trupin; Lianne Gensler; Patricia P Katz; Edward H Yelin; Stuart A Gansky; Jinoos Yazdany
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.